Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01420562

Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Status
Recruiting
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to calculate pharmacokinetic parameters and to evaluate the trough levels of posaconazole reached in patients with different stages of mucositis, due to chemotherapy and total body irradiation.

Conditions

Interventions

TypeNameDescription
PROCEDUREblood samplingDuring posaconazole treatment, blood sampling will occur on day 0 (=day of transplantation), day 7 and 14 to correlate posaconazole exposure to severity of mucositis.

Timeline

Start date
2011-09-01
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2011-08-19
Last updated
2024-07-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01420562. Inclusion in this directory is not an endorsement.